Recipharm and Consort Medical have reached an agreement on the terms of a recommended cash offer by Recipharm Holdings Limited, a wholly-owned direct subsidiary of Recipharm, for Consort. The Board of Consort has confirmed its unanimous intention to recommend a cash offer for an equity value of GBP 505 million (approximately SEK 6,284 million).

Recipharm är ett ledande CDMO-företag (Contract Development and Manufacturing Organisation) inom läkemedelsindustrin och har nära 7 000 anställda. Recipharm erbjuder tillverkningstjänster av läkemedel i olika former, produktion av material till kliniska prövningar och API:er, samt farmaceutisk produktutveckling. Recipharm tillverkar

On March 5, 2021, Recipharm AB (publ) was delisted from the stock exchange and became a private company owned by private equity firm EQT IX through Roar BidCo AB. About Recipharm. About Recipharm. Annual General Meeting 2021; Board of Directors; Group Management Team (GMT) Recipharm in brief; Sustainability; Investor relations; Careers. Working at Recipharm; The Recipharm story; Meet our employees; Current vacancies; Contact. Contact us; Development services contacts; Manufacturing services contacts; Locations.

Recipharm investor relations

The company invites investors, analysts and media to a web conference (in English) on 27 th July at 10:00 am CEST, where CEO Thomas Eldered and CFO Tobias Hägglöv will Invitation to the presentation of Recipharm’s interim report January - March 2020 Mon, May 04, 2020 08:00 CET. Recipharm AB will publish its interim report for January - March 2020 on 7 th May at 07:45 am CET.. The company invites investors, analysts and media to a web conference (in English) on 7 th May at 10:00 am CET, where CEO Thomas Eldered and CFO Tobias Hägglöv will present and To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription.

(London time) on 23 January 2020, Recipharm either owned or had 2019-11-18 · Swedish pharmaceutical group Recipharm has agreed to buy British peer Consort Medical for 505 million pounds or 6.3 billion crowns ($649 million), the companies said on Monday. Intresserad av ämnet Recipharm? Här hittar du samtliga artiklar, kommentarer och analyser om Recipharm från Dagens industris redaktion.

Recipharm AB will publish its interim report for the third quarter 2020 on 5[th] November at 07:45 am CET.The company invites investors,

RECIPHARM MONTS*. 4.

Investor relations. Financial news. Financial information. Financial press; Recipharm AB publishes report for the fourth quarter and full year 2020 2021.01.28

Recipharm Contacts Thomas Eldered, CEO, telephone: +46 8 602 52 10 Jean-François Hilaire, Executive Vice President, telephone: +33 695 447 507 Tobias Hägglöv, CFO, ir@recipharm.com, telephone: +46 8 602 52 00 Kendall Investor Relations, Carlo Tanzi, Ph.D., ctanzi@kendallir.com, telephone +1 (617) 914-0008 This information is information that Recipharm AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. Recipharm publishes Annual Report 2019 Wed, Apr 15, 2020 12:00 CET. Recipharm publishes its 2019 Annual Report today. The report summarises the business and highlights for 2019 and gives insights into the company’s strategy. Recipharm names 2020 International Environmental Award winner Tue, Mar 02, 2021 14:00 CET. Global contract development and manufacturing organisation (CDMO), Recipharm has announced its 2020 International Environmental Award will be presented to Dr. Amy Pruden, Professor of Civil and Environmental Engineering at Virginia Tech in Blacksburg, Virginia, USA. Dr. Pruden is widely recognised for Buyout group EQT on Monday announced a cash offer for Swedish contract pharmaceutical maker Recipharm, valuing the company at 23.6 billion Swedish crowns ($2.80 billion). Delisting of shares from Nasdaq Stockholm Fri, Feb 19, 2021 14:00 CET. As communicated by Recipharm AB (publ) (“Recipharm”) by way of a press release published on 15 February 2021, the board of directors of Recipharm has applied for delisting of Recipharm’s B-shares from Nasdaq Stockholm.

Financial press; Recipharm AB publishes report for the fourth quarter and full year 2020 2021.01.28 Recipharm is listed on NASDAQ Stockholm since April 3rd 2014. View Recipharm's regulatory and share & index information here. Announcement of consent solicitation by Recipharm AB (publ) in respect of its SEK 1,000,000,000 Senior Unsecured Convertible Bonds due 2021 (ISIN: XS1496895753) 2021.01.11 Read more Financial Press Investor relations. Financial news. Financial information.
Äkta polkakarameller

The Recipharm B-share (RECI B) is listed on Nasdaq Stockholm. Recipharm tillverkar flera hundra olika produkter åt såväl stora läkemedelsföretag som mindre utvecklingsbolag. Bolaget omsätter cirka 11 miljarder kronor per år och har utvecklings- och tillverkningsanläggningar i Frankrike, Indien, Israel, Italien, Portugal, Spanien, Storbritannien, Sverige, Tyskland och USA med huvudkontor i Stockholm, Sverige.

The Investor Relations website contains information about Sinch AB (publ)'s business for stockholders, potential investors, and financial analysts. Recipharm B shows strong development within a risi This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.
Buffett 5g stock

About Recipharm. Board of Directors; Group Management Team (GMT) Recipharm in brief; Sustainability; Investor relations; Empleo. Trabajar en Recipharm; La historia de Recipharm; Conozca a nuestros empleados; Vacantes actuales; Contact. Contact us; Development services contacts; Manufacturing services contacts;

Recipharm kommer i ett första steg finansiera sitt bud på brittiska Consort med bankkrediter inklusive ett brygglån om 2 miljarder kronor.

2019-11-18 · Swedish pharmaceutical group Recipharm has agreed to buy British peer Consort Medical for 505 million pounds or 6.3 billion crowns ($649 million), the companies said on Monday.

Welcome. Ad-hoc Disclosures Result Center IR Events Calendar Management 2021-04-16 Investor relations. On March 5, 2021, Recipharm AB (publ) was delisted from the stock exchange and became a private company owned by private equity firm EQT IX through Roar BidCo AB. About Recipharm. About Recipharm. Annual General Meeting 2021; Board of Directors; Group Management Team (GMT) Recipharm in brief; Sustainability; Investor relations; Careers. Working at Recipharm; The Recipharm story; Meet our employees; Current vacancies; Contact. Contact us; Development services contacts; Manufacturing services contacts; Locations.

The Netherlands +31 773 55 66 66. john.gilardi@ Certain of Recipharm's larger institutional shareholders, Första AP-fonden, Lannebo Fonder and Fjärde AP-fonden (holding 7.4%, 7.1% and 5.1% of the total number of shares in Recipharm, respectively, and together 19.6%), support the cash offer for Consort Medical and have undertaken to fully support and vote in favour of a rights issue at a forthcoming general meeting of Recipharm and have Om Recipharm Recipharm är ett ledande CDMO-företag (Contract Development and Manufacturing Organisation) inom läkemedelsindustrin och har cirka 5 000 anställda. Recipharm erbjuder tillverkningstjänster av läkemedel i olika former, produktion av material till kliniska prövningar och API:er, samt farmaceutisk produktutveckling. Recipharm Investors. Investor Relations (Global) Investor Relations (Sweden) Resources Governance Shareholder information Dividend policy Key facts FAQs Debt Investors ADR Programme Media.